Literature DB >> 22588968

Detection of exercise-induced pulmonary arterial hypertension by cardiopulmonary exercise testing.

Martin Schwaiblmair1, Christian Faul, Wolfgang von Scheidt, Thomas M Berghaus.   

Abstract

BACKGROUND: The pulmonary arterial pressure (PAP) response to exercise may provide a tool for the early detection of pulmonary arterial hypertension (PAH). Therefore, an accurate noninvasive method for evaluating exercise-induced PAH (EIPAH) is desirable. HYPOTHESIS: We sought to examine if cardiopulmonary exercise testing (CPET) is able to indicate EIPAH.
METHODS: Fifty-three patients aged 67.1 ± 1.7 years (37 female, 16 male) with borderline PAH (resting mean PAP 21-24 mm Hg) performed CPET and right heart catheterization at rest and during handgrip testing.
RESULTS: When comparing patients with an exercise-induced mean PAP ≥ mm Hg (group A, n = 24) and subjects with an exercise-induced mean PAP <35 mm Hg (group B, n = 29), group A had a significantly lower mean aerobic capacity (15.2 ± 1.2 vs 19.7 ± 1.2 mL/min/kg; P = 0.02), higher ventilatory equivalents for oxygen at the anaerobic threshold (34.3 ± 1.5 vs 29.9 ± 1.1; P = 0.02), a widening of the mean alveolar-arterial oxygen difference (37.8 ± 3.0 vs 26.8 ± 2.4 mm Hg; P = 0.007), an elevated mean functional dead space ventilation (29.5 ± 2.7 vs 21.2 ± 1.7%; P = 0.008), and a higher mean arterial to end-tidal carbon dioxide gradient at peak exercise (3.7 ± 0.9 vs 0.4 ± 0.8 mm Hg; P = 0.007).
CONCLUSIONS: EIPAH is characterized by a decreased ventilatory efficiency due to ventilation to perfusion inequalities. CPET may be useful for the identification of EIPAH and serve to diagnose PAH at an early stage.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22588968      PMCID: PMC6652325          DOI: 10.1002/clc.22009

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  34 in total

1.  Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension.

Authors:  D A Raeside; A Smith; A Brown; K R Patel; R Madhok; J Cleland; A J Peacock
Journal:  Eur Respir J       Date:  2000-08       Impact factor: 16.671

2.  Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide.

Authors:  M S Riley; J Pórszász; M P Engelen; S M Shapiro; B H Brundage; K Wasserman
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

3.  Exercise pathophysiology in patients with primary pulmonary hypertension.

Authors:  X G Sun; J E Hansen; R J Oudiz; K Wasserman
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

4.  Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise.

Authors:  Friedrich C Blumberg; Günter A J Riegger; Michael Pfeifer
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

5.  Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring.

Authors:  D A Raeside; G Chalmers; J Clelland; R Madhok; A J Peacock
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

6.  Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene.

Authors:  E Grünig; B Janssen; D Mereles; U Barth; M M Borst; I R Vogt; C Fischer; H Olschewski; H F Kuecherer; W Kübler
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

7.  Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

Authors:  S Miyamoto; N Nagaya; T Satoh; S Kyotani; F Sakamaki; M Fujita; N Nakanishi; K Miyatake
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

8.  Exercise hemodynamic findings in patients with exertional dyspnea.

Authors:  K B James; J Maurer; K Wolski; S R Lutton; G Haas; R Schilz; D Rubin; J B Young
Journal:  Tex Heart Inst J       Date:  2000

9.  Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans.

Authors:  M S Riley; J Pórszász; M P Engelen; B H Brundage; K Wasserman
Journal:  Eur J Appl Physiol       Date:  2000-09       Impact factor: 3.078

10.  Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension.

Authors:  Xing-Guo Sun; James E Hansen; Ronald J Oudiz; Karlman Wasserman
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

View more
  4 in total

1.  Exercise-induced pulmonary artery hypertension in a patient with compensated cardiac disease: hemodynamic and functional response to sildenafil therapy.

Authors:  Lazaros Nikolaidis; Nabeel Memon; Brian O'Murchu
Journal:  Tex Heart Inst J       Date:  2015-02-01

2.  Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension.

Authors:  Qin-Hua Zhao; Lan Wang; Bigyan Pudasaini; Rong Jiang; Ping Yuan; Su-Gang Gong; Jian Guo; Qiang Xiao; Hui Liu; Cheng Wu; Zhi-Cheng Jing; Jin-Ming Liu
Journal:  Clin Cardiol       Date:  2016-11-02       Impact factor: 2.882

3.  Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.

Authors:  Sulaiman Surie; Herre J Reesink; J Tim Marcus; Mart N van der Plas; Jaap J Kloek; Anton Vonk-Noordegraaf; Paul Bresser
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

4.  Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development.

Authors:  Olga Rafikova; Imad Al Ghouleh; Ruslan Rafikov
Journal:  Antioxid Redox Signal       Date:  2019-07-02       Impact factor: 8.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.